Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
294 studies found for:    glioblastoma | Open Studies
Show Display Options
Rank Status Study
21 Recruiting Determination of Immune Phenotype in Glioblastoma Patients
Condition: Glioblastoma Multiforme
Intervention: Procedure: Surgery
22 Recruiting Intraoperative Radiotherapy in Newly Diagnosed Glioblastoma Multiforme
Condition: Glioblastoma
Interventions: Procedure: Standard surgery (neuronavigation-guided);   Radiation: Intraoperative radiotherapy;   Radiation: Radiochemotherapy;   Drug: Temozolomide
23 Recruiting Impact of iMRI on the Extent of Resection in Patients With Newly Diagnosed Glioblastomas
Condition: Glioblastoma
Interventions: Device: iMRI-guided surgery;   Drug: 5-ALA-guided surgery
24 Recruiting Surgery for Recurrent Glioblastoma
Condition: Glioblastoma
Interventions: Procedure: Surgery followed by adjuvant second-line therapy;   Procedure: Second-line therapy alone
25 Recruiting Spatial Analysis and Validation of Glioblastoma on 7 T MRI
Condition: Glioblastoma
Interventions: Device: 7 T MRI;   Procedure: Biopsy
26 Recruiting Prevention of Thrombocytopenia in Glioblastoma Patients
Conditions: Thrombocytopenia;   Glioblastoma
Intervention: Drug: Romiplostim
27 Recruiting Study of LY2228820 With Radiotherapy Plus Concomitant TMZ in the Treatment of Newly Diagnosed Glioblastoma
Condition: Adult Glioblastoma
Interventions: Drug: LY2228820;   Drug: Temozolomide;   Radiation: radiotherapy
28 Not yet recruiting Feasibility Study on LITT for Newly Diagnosed Glioblastoma
Condition: Glioblastoma
Intervention: Device: NeuroBlate System
29 Not yet recruiting Preliminary Assessment of [18F] Fluciclatide (GE [18F]AH111585) in Glioblastoma Multiforme Treated With Bevacizumab
Condition: Glioblastoma Multiforme (GBM)
Intervention: Drug: Fluciclitite , PET imaging, and Bevacizumab
30 Recruiting Phase I Study of a Dendritic Cell Vaccine for Patients With Either Newly Diagnosed or Recurrent Glioblastoma
Conditions: Glioblastoma;   Glioblastoma Multiforme;   Glioma;   Astrocytoma;   Brain Tumor
Interventions: Biological: Dendritic cell vaccination, in addition to standard temozolomide chemotherapy and involved field radiation therapy;   Biological: Dendritic cell vaccination, with optional bevacizumab treatment for patients previously treated with bevacizumab
31 Recruiting A Study of Subcutaneous Bevacizumab in Relapsed / Progressive Glioblastoma
Condition: Glioblastoma
Intervention: Drug: Bevacizumab 25 mg in 1 ml subcutaneously daily
32 Recruiting Personalized Cellular Vaccine for Glioblastoma (PERCELLVAC)
Condition: Glioblastoma
Intervention: Biological: Personalized cellular vaccine
33 Recruiting Phase III Study Comparing 2 Brain Conformational Radiotherapy in Combination With Chemotherapy in the Treatment of Glioblastoma
Condition: Glioblastoma
Interventions: Radiation: Radiotherapy;   Radiation: Experimental arm
34 Recruiting Early Stereotactic Gamma Knife Radiosurgery to Residual Tumor After Surgery of Newly Diagnosed Glioblastoma
Condition: Glioblastoma
Intervention: Radiation: gamma knife radiosurgery (15 Gy to 50% isodose)
35 Recruiting T Cells Expressing HER2-specific Chimeric Antigen Receptors(CAR) for Patients With Glioblastoma
Condition: Glioblastoma
Intervention: Genetic: HER2-specific T cells
36 Recruiting Bevacizumab w / Temozolomide PET & Vascular MRI For GBM
Condition: Recurrent Glioblastoma
Interventions: Device: MRI-PET;   Device: TMZ-PET
37 Not yet recruiting Validation of the Role of Levetiracetam for Newly Diagnosed GBM Patients
Condition: Glioblastoma Multiforme
Intervention: Drug: levetiracetam
38 Recruiting Capecitabine + Bevacizumab in Patients With Recurrent Glioblastoma
Condition: Glioblastoma
Interventions: Drug: Capecitabine;   Drug: Bevacizumab
39 Recruiting Hypofractionated Stereotactic Radiotherapy in Recurrent Glioblastoma Multiforme
Condition: Recurrent Glioblastoma Multiforme
Interventions: Radiation: Stereotactic hypofractionated RT 5x5Gy;   Radiation: Stereotactic hypofractionated RT 5x7Gy
40 Recruiting Peptide Targets for Glioblastoma Against Novel Cytomegalovirus Antigens
Conditions: Glioblastoma;   Glioblastoma Multiforme
Interventions: Drug: 5-day TMZ;   Drug: 21-day TMZ;   Biological: PEP-CMV;   Drug: Tetanus-Diphtheria booster;   Drug: Tetanus Pre-Conditioning

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.